AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Glimeto MV 1mg/500mg/0.2mg Tablet

Prescription Icon
Prescription Required

Marketer

Exito Pharma

Salt Composition

Glimepiride (1mg) + Metformin (500mg) + Voglibose (0.2mg)

Overview Glimeto MV 1mg/500mg/0.2mg Tablet

Glimeto MV 1mg/500mg/0.2mg tablets are classified as antidiabetic medications, a combination therapy for adult type 2 diabetes mellitus. This medication helps manage blood glucose levels. Administer Glimeto MV with food, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may adjust based on blood sugar monitoring. Continuous use is crucial; discontinuation without medical consultation risks elevated blood sugar, potentially leading to kidney complications, vision impairment, neuropathy, and limb loss. This medication is one component of a comprehensive diabetes management plan, encompassing diet, exercise, and weight management as directed by your doctor. Lifestyle choices significantly impact diabetes control. Hypoglycemia (low blood sugar) is the most frequent adverse effect, characterized by symptoms like sweating, dizziness, headache, and tremors. Regular meals and readily available glucose sources (e.g., sugary snacks, juice) are vital for hypoglycemia prevention. Alcohol consumption should be limited due to its potential to exacerbate hypoglycemia. Additional possible side effects include altered taste, nausea, diarrhea, abdominal discomfort, headache, swelling (edema), blurred vision, bone fractures, and upper respiratory infections. Weight gain may occur. This medication is contraindicated in individuals with type 1 diabetes, diabetic ketoacidosis, or severe hepatic or renal impairment. Prior heart disease should be disclosed to your physician before commencing treatment. Pregnant or lactating individuals require medical consultation before use. Regular blood glucose monitoring is essential, and your doctor might recommend blood tests to track blood cell counts and liver function.

Primary Ingredients of Glimeto MV 1mg/500mg/0.2mg Tablet

The provided text is "undefined," offering no content to rephrase.

Uses of Glimeto MV 1mg/500mg/0.2mg Tablet

Managing type 2 diabetes

Major Benefits of Glimeto MV 1mg/500mg/0.2mg Tablet:

Consume this medication precisely as your physician directs, adhering to the prescribed dosage and timeframe. Ingest the entire tablet without chewing, crushing, or fracturing it. The Glimeto MV 1mg/500mg/0.2mg tablet should be taken on an empty stomach.

Common Side effects of Glimeto MV 1mg/500mg/0.2mg Tablet:

  • Nausea
  • Diarrhea
  • Abdominal pain
  • Hypoglycemia (low blood glucose level)
  • Loss of appetite

How to use Glimeto MV 1mg/500mg/0.2mg Tablet:

Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Glimeto MV 1mg/500mg/0.2mg tablets should be taken on an empty stomach.

How Glimeto MV 1mg/500mg/0.2mg Tablet works:

Glimepiride, metformin, and pioglitazone, each at a dose of 1mg, 500mg, and 0.2mg respectively, are combined in a single Glimeto MV tablet.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Glimeto MV 1mg/500mg/0.2mg tablets with alcohol is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Glimeto MV 1mg/500mg/0.2mg tablets during pregnancy might pose risks. While human research is scarce, animal studies indicate potential harm to a developing fetus. A physician will assess the advantages against possible dangers prior to prescribing this medication. Seek medical advice before taking this drug.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Lactation and Glimeto MV 1mg/500mg/0.2mg tablets are likely incompatible. Preliminary human evidence indicates potential drug transfer to breast milk, posing a risk to the infant.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyUNSAFE

Patients with kidney disease should likely avoid Glimeto MV 1mg/500mg/0.2mg Tablets due to potential safety concerns. Medical advice is recommended. Furthermore, this medication is unsuitable for individuals with severe kidney impairment.

LiverLiverCAUTION

Patients with liver impairment should use Glimeto MV 1mg/500mg/0.2mg tablets cautiously, potentially requiring dose modification. Consult a physician. For individuals with mild to moderate liver disease, initiation should be at a low dosage; the medication is contraindicated in those with severe hepatic dysfunction.

What if you forget to take Glimeto MV 1mg/500mg/0.2mg Tablet :

Should you forget a Glimeto MV 1mg/500mg/0.2mg Tablet dose, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual medication timetable. Avoid taking a double dose.

Facts to Know About Glimeto MV 1mg/500mg/0.2mg Tablet

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Glimeto MV 1mg/500mg/0.2mg Tablet

Glimeto MV 1mg/500mg/0.2mg tablets combine glimepiride, metformin, and voglibose to manage type 2 diabetes mellitus (DM) in adults. This combination improves blood glucose control when used with diet and exercise. Glimepiride stimulates insulin release; metformin reduces liver glucose production and enhances insulin sensitivity; and voglibose, an alpha-glucosidase inhibitor, lowers postprandial glucose. This medication is not suitable for type 1 DM.
Glimeto MV 1mg/500mg/0.2mg tablets may cause common side effects including hypoglycemia, nausea, diarrhea, taste changes, flatulence, abdominal pain, headache, rash, and respiratory infections.
Glimeto MV 1mg/500mg/0.2mg Tablets are contraindicated in patients allergic to any component or excipient. Avoid use in patients with moderate to severe kidney disease, inflammatory bowel disease, colonic ulcerations, or underlying metabolic acidosis, including diabetic ketoacidosis.
Combining Glimeto MV 1mg/500mg/0.2mg tablets with alcohol is unsafe. This combination can worsen low blood sugar and raise the risk of lactic acidosis.
Glimeto MV 1mg/500mg/0.2mg Tablets can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heart rate, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other antidiabetic medications. Therefore, regular blood sugar monitoring is crucial. Always carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice.
Store this medication, tightly sealed, in its original container. Follow the storage instructions on the packaging. Discard any unused medication; ensure it remains inaccessible to children, pets, and others.
Glimeto MV 1mg/500mg/0.2m...
74
MRP 90
17% off